Bernanke Joins Anthropic's Long-Term Benefit Trust
Taylor Wilson
Former Fed Chair and Nobel laureate Ben Bernanke has joined Anthropic's top oversight body — the Long-Term Benefit Trust — as its fourth trustee; the $965 billion-valued AI company, which has reportedly filed a confidential IPO application, is trying to bolt a mission-protection lock onto its governance before going public.
What is this trust, and why does it outrank the board?
The LTBT — Long-Term Benefit Trust — is the apex oversight body in Anthropic's governance: trustees hold no equity and receive no profit share, paid only for time served, yet they hold the power to appoint and remove board members.
This means → trustees have no financial stake to protect, but they control who sits on the board — a deliberately designed role with "brakes only, no gas pedal."
That power is set to expand over time until the LTBT controls a board majority, making its grip on company direction stronger with each passing year.
In plain terms = the board decides how the company runs; the LTBT decides who sits on the board — it is an external lock Anthropic installed on itself.
Why pick a former central-bank chief?
Bernanke chaired the Federal Reserve from 2006 to 2014, steering the U.S. through the 2008 global financial crisis. Before that he spent over two decades at Princeton and other universities studying the Great Depression and banks' role in financial crises, work that earned him the 2022 Nobel Prize in Economics.
Anthropic co-founder Daniela Amodei put it bluntly: AI may produce the most significant economic impact of any technology in modern history, and the company has a dual responsibility — to understand those effects and to act on them.
This means → Anthropic sees AI's greatest risk not just as technical failure but as systemic economic shock — and wants someone who has actually navigated a systemic crisis standing guard.
What does Bernanke himself say?
Bernanke stated: "The potential of AI is enormous, and so is the range of its possible outcomes. Much will depend on the institutions we build around it."
He described Anthropic's governance structure as unique — an attempt to ensure AI's long-term benefits to humanity far outweigh its risks.
This reflects a core judgment from an economist's lens: technology alone does not determine outcomes — institutional design does.
Who are the other three trustees, and what skill set do they form?
LTBT chair Neil Buddy Shah, CEO of the Clinton Health Access Initiative — a public-health and global-development background.
Richard Fontaine, a national-security expert, and Mariano-Florentino Cuéllar, an international-affairs specialist.
In plain terms = four people covering economic crises, public health, national security, and international governance — all "who catches the system when it breaks" roles, with not a single tech or business profile among them.
With an IPO looming, can this structure actually hold?
Anthropic is registered as a Public Benefit Corporation (PBC), a legal form that requires the company to balance commercial interests with public benefit. The LTBT is the institutional safeguard behind that requirement.
The company's valuation has reached $965 billion; it has reportedly filed a confidential IPO application and could list as early as October this year.
This means → doubts over whether "the mission will be diluted by capital markets" are not going away — the real test for the LTBT is not today's appointment but what happens after listing, when shareholder-return pressure collides with the safety mission and trustees must decide whether to actually use their power.
Content is for reference only, not financial advice.